Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 510

MiRagen Therapeutics gains $20m

Remeditex Ventures, set up in part by technology transfer professionals at Texas University's UT Southwestern Medical Center, is joined by Amgen's corporate venturing unit backing the round.

Apr 26, 2012

MiRagen Therapeutics gains $20m

Remeditex Ventures, a US-based venture capital (VC) firm set up by former executives at Hunt Petroleum and technology transfer professionals at Texas University's UT Southwestern Medical Center, led MiRagen's round, and was joined by peers Atlas Venture, Boulder Ventures and Broadview Ventures, as well as Amgen.

Apr 26, 2012

Intel helps ScienceLogic deduce $15m

Intel Capital backs the cloud software company, joining New Enterprise Associates in the syndicate.

Apr 24, 2012

D.cn games to $20m

Saif Partners, backed by US-based technology company Cisco, reportedly takes D.Cn to $20m round.

Apr 23, 2012

Arvia raises $6.1m

University of Manchester spin-out Arvia Technology, which treats organic liquid waste, has raised money from prior backer MTI, as well as investors Sustainable Technology Investors and Park Walk Advisors.

Apr 19, 2012

OneRoof shines for $3m

The residential solar leasing company backed by Hanwha International raises the funds after a $50m round in September last year.

Apr 19, 2012

Path paved with $30m

Path wins backing from Allen & Co, Richard Branson and Yuri Milner, taking it to more than $30m raised.

Apr 18, 2012

BBC docks into Spaceport.io

The BBC reportedly backs the US-based game developer platform and plans to design games and apps using its technology.

Apr 12, 2012

Intel finds Oasys

Chip design systems company gets backed by sector giant Intel's corporate venturing unit for its latest round.

Apr 10, 2012

Intel pumps up Minha Vida

Intel backs Brazil-based health and wellness company with more than 8 million unique users per month.

Apr 10, 2012
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here